Owner of Daar Communications Limited, publisher of AIT and Raypower Radio broadcasting station, Chief Raymond Dokpesi has said that he was treated with malaria medication to get him out of coronavirus for which he was confined into Gwagwalada isolation centre.
Dokpesi, who was tested negative after some days in isolation and treatment from coronavirus and discharged from the center yesterday, May 15, in a trending video clip, stressed that he did not see any difference between malaria and coronavirus.
“Every medication we were given (in the isolation centre), was malaria medication.
“Even some people before being told they were Covid 19 positive were tested in reputable laboratories in Abuja: in hospitals in Abuja. What they found was that they had a lot of malaria parasites in their blood stream. So, when did malaria become synonymous with Covid 19? That is food for thought.”
Chief Dokpesi, who commended Nigeria medical personnel for the professional ways they have been handling patients in isolation centres, stressed that he still has doubt in his mind about the reality of the coronavirus.
“I still want to be properly educated (I’m a bloody mechanic): what is the difference between Covid 19, which is a virus and malaria which is mosquito induced.”
Published by Greenbarge Media & Communications Limited, and is conceptualized on developmental journalism with emphasis on reforming the best way for human being across the globe to interact, based on understanding, friendliness, and tolerance.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.